Vaughan Clift - Ampio Pharmaceuticals Insider

AMPE -- USA Stock  

USD 2.16  0.50  30.12%

Chief Regulatory Affairs Officer

Dr. Vaughan Lennox Clift, M.D., serves as Chief Regulatory Affairs Officer of Ampio Pharmaceuticals, Inc. Dr. Clift was employed as Ampios Chief Regulatory Affairs Officer from March 2010 until July 2016 and was employed by Life Sciences from May 2009 until March 2010. From 2005 to 2009, Dr. Clift was the chief executive officer of Detectachem LLC, a Houston, Texasbased manufacturer of a handheld explosive and narcotics detection device. Dr. Clift was the Vice President of Operations for Isolagen from 2002 until 2005.
Age: 54        
720-437-6500  http://www.ampiopharma.com

Management Efficiency

The company has return on total asset (ROA) of (79.05) % which means that it has lost $79.05 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (253.19) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Entity Summary

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado. Ampio Pharmaceuticals operates under Biotechnology classification in USA and traded on American Stock Exchange. It employs 17 people.Ampio Pharmaceuticals (AMPE) is traded on American Stock Exchange in USA. It is located in COLORADO, U.S.A and employs 17 people. Ampio Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

Ampio Pharmaceuticals Leadership Team

Thomas Chilcott, CFO
Vaughan Clift, Executive
Holli Cherevka, COO
David Stevens, Director
Philip Coelho, Chairman
Richard Giles, Chairman, CPA
Gregory Gould, CFO
David BarOr, Director
Michael MacAluso, Chairman

Stock Performance Indicators

Current Sentiment - AMPE

Ampio Pharmaceuticals Investor Sentiment
Most of Macroaxis users are presently bullish on Ampio Pharmaceuticals. What is your sentiment towards investing in Ampio Pharmaceuticals? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Ampio Pharmaceuticals and NantKwest. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.